COMMUNIQUÉS West-GlobeNewswire

Wave Life Sciences Announces Initiation of DYSTANCE 51, a Phase 2/3 Clinical Trial of Suvodirsen
27/06/2019
Global study designed to assess the efficacy and safety of suvodirsen in DMD patients amenable to exon 51 skipping Results intended to support regulatory approvals globally CAMBRIDGE, Mass., June 27, 2019 (GLOBE [...]
Entasis Therapeutics Announces New Results Supporting Advancement of Multiple Pathogen-Targeted Antimicrobial Programs at ASM Microbe 2019
27/06/2019
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Aucta Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application
27/06/2019
PISCATAWAY, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. ( Aucta ), a technology based company focusing on the development and commercialization of Branded Specialty Products, today announced that [...]
Zogenix Announces FDA Agreement to Proceed with Resubmission of FINTEPLA® NDA
27/06/2019
NDA resubmission, anticipated in third quarter 2019, can proceed without additional chronic toxicity studies EMERYVILLE, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical [...]
Todos Medical to Sponsor the Investacure ‘Cure Coin Awards Reception’ for Alzheimer’s and CTE Research at AAIC 2019 in Los Angeles
27/06/2019
REHOVOT, Israel, June 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
CareDx Supports Momentum in Medicare Immunosuppressive Medication Legislation
27/06/2019
Kidney community rallies in support as introduction of the immunosuppression coverage bill is imminent BRISBANE, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics [...]
Apellis Pharmaceuticals Completes Enrollment of Phase 3 APL-2 (pegcetacoplan) Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab
27/06/2019
Top-line Data Anticipated in December 2019 CRESTWOOD, Ky. and WALTHAM Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the [...]
Publishing of Orion Corporation's Half Year Report for January-June 2019 on 17 July 2019
27/06/2019
ORION CORPORATION PRESS RELEASE 27 JUNE 2019 at 14.30 EEST Publishing of Orion Corporation's Half Year Report for January-June 2019 on 17 July 2019 Orion will publish its Half Year Report for January-June 2019 on [...]
ProMIS Neurosciences’ PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed Antibodies
27/06/2019
Data presented at Keystone Symposium on Neurodegenerative Diseases TORONTO, Ontario and CAMBRIDGE, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company [...]
OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy
27/06/2019
Collaborator data demonstrating OpGen’s rapid prediction of antibiotic resistance and detection of uropathogens presented at ASM Microbe 2019 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: [...]
Prolaris® Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer
27/06/2019
Validation Study Shows Prolaris Test Identifies Men Who May Benefit from Surgery or Radiation at the Time of a Prostate Cancer Diagnosis SALT LAKE CITY, June 27, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: [...]
XBiotech remporte le « Prix de l'immobilier commercial pour le développement industriel » pour son siège social situé à Austin, au Texas
27/06/2019
AUSTIN, Texas, 27 juin 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) a annoncé aujourd'hui être le récipiendaire du premier prix 2019 de l'immobilier commercial pour le développement industriel, choisi par l' [...]
Assembly Biosciences Announces First Patient Dosed with ABI-M201 in Phase 1b Clinical Trial for Mildly to Moderately Active Ulcerative Colitis
27/06/2019
First oral microbiome biologic drug candidate from Assembly’s novel microbiome platform to enter clinical trials in patients ABI-M201 utilizes Assembly’s proprietary and patented Gemicel ® capsule-in-capsule delivery [...]
Antares Pharma Announces Amendment to Existing Loan and Security Agreement With Hercules Capital
27/06/2019
Amendment Increases Loan By Up To $25 Million in Non-Dilutive Debt Financing EWING, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares” or “the Company”) today announced that it has [...]
HealthEquity to Acquire WageWorks Accelerating Market-Wide Transition to HSAs
27/06/2019
Delivers sustained growth, significant synergies, rapid deleveraging DRAPER, Utah and SAN MATEO, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation's largest [...]
Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™
27/06/2019
Pivotal Phase 3 clinical trial expected to initiate in the fall of 2019 Top-line clinical data expected in the first quarter of 2020 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a [...]
NeuroMetrix Provides Strategic Update
27/06/2019
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company addressing chronic health conditions including chronic pain, sleep disorders and diabetes, today reported on [...]
Trevena Appoints Barry Shin as Chief Financial Officer
27/06/2019
CHESTERBROOK, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System [...]
AgraFlora Organics Provides Licensing Guidance and Operational Updates at GMP-Certified GTA Bottling Facility
27/06/2019
VANCOUVER, British Columbia, June 27, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]

Pages